Classification Of Childhood Malignant Tumors And Principles Of Radiotherapy
At present, pediatric malignant tumor has become one of the main causes of death in children. Malignant tumors in children have different characteristics compared with
At present, pediatric malignant tumor has become one of the main causes of death in children. Malignant tumors in children have different characteristics compared with
There are currently no new disease-modifying therapies that can change the progression of Parkinson’s disease, but scientists from the University of Colorado and other institutions
The toxicity of ADC drugs mainly comes from two aspects, namely the toxicity produced by antibody molecules and the toxicity produced by toxin molecules. The
Recently, Pfizer announced a new organizational structure adjustment, which will take effect before September 1, 2022, and its business will focus more on COVID-19-related products.
Association Between Sugar-Sweetened Beverage Intake and Liver Cancer Risk in the Women’s Health Initiative. Nutrition A study in the European Prospective Project on Cancer and
The basic principle of fluorescence microscopy is the highly specific visualization of cellular components with the aid of fluorescent dyes. This may be a fluorescent
A rationale for fluorescent dyes is the highly specific visualization of cellular components with the help of fluorescent agents. It can be a fluorescent protein,
Immune cells in a broad sense refer to all cells involved in or related to immune responses, mainly all leukocytes and non-leukocyte antigen-presenting cells (such
Fluorescein is divided into four categories according to the excitation wavelength, which are mainly 375nm, 405nm, 488nm and 633nm. Among them, fluoresceins with excitation wavelengths
Monoclonal antibody drugs, the full name is also known as monoclonal antibody drugs. As the name suggests, these drugs are closely related to the body’s
Basel, 6 July 2022 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s
YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer ScienceDirect Cancer immunotherapy is a breakthrough for